MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
FTH — Faeth Therapeutics, Inc. Common Stock
NasdaqFaeth Therapeutics, Inc. Common Stock
$28.35
+0.08(+0.28%)
- O
- 28.32
- H
- 29.50
- L
- 27.37
- V
- 187.92K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About FTH
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateFeb 4, 2021
Employees29
Stock ExchangeNasdaq
Ticker SymbolFTH
Key Financial Statistics
| Market Cap | $732.58M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $7.45 - $42.14 |
| 52-Week Avg Volume | 199.0K |
| VWAP | $28.26 |
| Transactions | 4,836 |
| Total Recorded Bars | 1,422 days |